Sarah Cusworth, MD
Obstetrics & Gynecology · Saint Louis, MONPI 1306251525
Payments from drug & device makers
Across 120 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$675
- Coopersurgical, Inc.$205
- Evofem Biosciences, Inc.$203
- Meditrina$128
- Organon$118
- Avion Pharmaceuticals$83
- plus $775 from 19 others
What the payments were for
- Food & beverage$2,14498%
- Education$432%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 38 | $675 |
| Coopersurgical, Inc. | 11 | $205 |
| Evofem Biosciences, Inc. | 12 | $203 |
| Meditrina | 4 | $128 |
| Organon | 6 | $118 |
| Avion Pharmaceuticals | 5 | $83 |
| Astellas Pharma US Inc | 4 | $82 |
| Agile Therapeutics, Inc. | 4 | $74 |
| Exeltis, USA Inc. | 4 | $67 |
| Merck | 4 | $65 |
| Mayne Pharma Commercial LLC | 3 | $60 |
| Hologic Sales And Service, LLC | 3 | $55 |
| Sumitomo Pharma America, Inc. | 2 | $48 |
| Millicent US Inc | 2 | $40 |
| Biohaven Pharmaceuticals, Inc. | 3 | $39 |
| Mylan Pharmaceuticals Inc. | 2 | $38 |
| Lupin Inc. | 2 | $36 |
| Bayer | 2 | $34 |
| Minerva Surgical, Inc | 2 | $30 |
| Vertical Pharmaceuticals, LLC | 2 | $28 |
| Shield Therapeutics Inc | 1 | $19 |
| Mission Pharmacal Company | 1 | $17 |
| AMAG Pharmaceuticals, Inc. | 1 | $16 |
| Axonics, Inc. | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
How this compares
$2,187 in reported general payments places this provider in the 75th percentile of 750 obstetrics & gynecology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 19 | $2,450 |
| Estradiol | 27 | $1,745 |
| ValacyclovirValacyclovir Hcl | 20 | $727 |
| Clobetasol Propionate | 13 | $312 |
| Alendronate Sodium | 19 | $36 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Saint Louis
- Becky LynnSaint Louis$231K
- Makeba WilliamsSaint Louis$48K
- Kimberly LemoineSaint Louis$30K
- David WeinsteinSaint Louis$25K
- Haifaa YounisSaint Louis$22K
- David KrausSaint Louis$16K
- Kaci DurbinSaint Louis$14K
- Wendi CarnsSaint Louis$14K
- Melissa TepeSaint Louis$11K
- Jill ScherbelSaint Louis$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.